Chairman’s Address to Shareholders at Annual General Meeting

Jul 22, 2020
Posted in: News, Investor updates

Home » Chairman’s Address to Shareholders at Annual General Meeting

Chairman’s Address to Shareholders at Annual General Meeting

Jul 22, 2020
Posted in: News, Investor updates

Imagion Biosystems announces the transcript of the Chairman’s address to shareholders at the Annual General Meeting.

Join Us at RSNA and SABCS: Advancing Molecular MRI for Cancer Detection

November 13, 2025

We are excited to announce that Imagion Biosystems (ASX: IBX) will be attending two premier medical conferences this fall: the Radiological Society of North

Positive Results Received from WSU on MagSense® Dosage – Phase 2 Clinical Trial on HER2 Breast Cancer Imaging Agent

November 5, 2025

FDA Submission of IND for MagSense® HER2 Phase 2 Clinical Trial on Track Q4 2025 Key Highlights: Wayne State University Collaboration Program Delivers Positive and

[Video] The Market Bull – Imagion Biosystems’ Magsense Non-invasive Cancer Detection

October 24, 2025

Video transcript: Advances in treatment for cancer have greatly improved survivability when the cancer is caught early. However, despite global spending of over $100

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Chairman’s Address to Shareholders at Annual General Meeting

Chairman’s Address to Shareholders at Annual General Meeting

Related Articles

Join Us at RSNA and SABCS: Advancing Molecular MRI for Cancer Detection

Positive Results Received from WSU on MagSense® Dosage – Phase 2 Clinical Trial on HER2 Breast Cancer Imaging Agent

[Video] The Market Bull – Imagion Biosystems’ Magsense Non-invasive Cancer Detection

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list